CA2286301A1 - Bacteriophage filamenteux utilise comme structure multivalente pour le couplage des peptides synthetiques - Google Patents

Bacteriophage filamenteux utilise comme structure multivalente pour le couplage des peptides synthetiques Download PDF

Info

Publication number
CA2286301A1
CA2286301A1 CA 2286301 CA2286301A CA2286301A1 CA 2286301 A1 CA2286301 A1 CA 2286301A1 CA 2286301 CA2286301 CA 2286301 CA 2286301 A CA2286301 A CA 2286301A CA 2286301 A1 CA2286301 A1 CA 2286301A1
Authority
CA
Canada
Prior art keywords
phage
peptide
pviii
mbp
recombinant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2286301
Other languages
English (en)
Inventor
Michael Bruce Zwick
Jamie Kathleen Scott
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA 2286301 priority Critical patent/CA2286301A1/fr
Publication of CA2286301A1 publication Critical patent/CA2286301A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/02—Libraries contained in or displayed by microorganisms, e.g. bacteria or animal cells; Libraries contained in or displayed by vectors, e.g. plasmids; Libraries containing only microorganisms or vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6075—Viral proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Plant Pathology (AREA)
  • Mycology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
CA 2286301 1999-11-01 1999-11-01 Bacteriophage filamenteux utilise comme structure multivalente pour le couplage des peptides synthetiques Abandoned CA2286301A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA 2286301 CA2286301A1 (fr) 1999-11-01 1999-11-01 Bacteriophage filamenteux utilise comme structure multivalente pour le couplage des peptides synthetiques

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA 2286301 CA2286301A1 (fr) 1999-11-01 1999-11-01 Bacteriophage filamenteux utilise comme structure multivalente pour le couplage des peptides synthetiques

Publications (1)

Publication Number Publication Date
CA2286301A1 true CA2286301A1 (fr) 2001-05-01

Family

ID=4164379

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2286301 Abandoned CA2286301A1 (fr) 1999-11-01 1999-11-01 Bacteriophage filamenteux utilise comme structure multivalente pour le couplage des peptides synthetiques

Country Status (1)

Country Link
CA (1) CA2286301A1 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012001004A1 (fr) * 2010-07-02 2012-01-05 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Vaccin à base de fimh contre les infections du système urinaire
EP2738256A2 (fr) * 2011-07-26 2014-06-04 Universidad Nacional Autónoma De México Utilisation du peptide gk-1 exprimé dans le phage filamenteux m13 pour l'élaboration de produits pharmaceutiques qui augmentent l'efficacité de la réponse immunitaire induite par des antigènes vaccinaux ou pathogènes
USRE45968E1 (en) 2005-12-27 2016-04-12 Sigma Tau Industrie Farmaceutiche Riunite S.P.A. Vector for efficient selection and/or maturation of an antibody and uses thereof

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE45968E1 (en) 2005-12-27 2016-04-12 Sigma Tau Industrie Farmaceutiche Riunite S.P.A. Vector for efficient selection and/or maturation of an antibody and uses thereof
WO2012001004A1 (fr) * 2010-07-02 2012-01-05 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Vaccin à base de fimh contre les infections du système urinaire
JP2013530707A (ja) * 2010-07-02 2013-08-01 シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニ ***症（ｕｔｉ）ワクチン
EP2738256A2 (fr) * 2011-07-26 2014-06-04 Universidad Nacional Autónoma De México Utilisation du peptide gk-1 exprimé dans le phage filamenteux m13 pour l'élaboration de produits pharmaceutiques qui augmentent l'efficacité de la réponse immunitaire induite par des antigènes vaccinaux ou pathogènes
EP2738256A4 (fr) * 2011-07-26 2015-04-15 Univ Nac Autónoma De México Utilisation du peptide gk-1 exprimé dans le phage filamenteux m13 pour l'élaboration de produits pharmaceutiques qui augmentent l'efficacité de la réponse immunitaire induite par des antigènes vaccinaux ou pathogènes

Similar Documents

Publication Publication Date Title
Bao et al. Phage-based vaccines
US6964769B2 (en) Molecular antigen array
Ren et al. Phage display of intact domains at high copy number: a system based on SOC, the small outer capsid protein of bacteriophage T4
Meola et al. Derivation of vaccines from mimotopes. Immunologic properties of human hepatitis B virus surface antigen mimotopes displayed on filamentous phage.
US5837268A (en) GnRH-leukotoxin chimeras
Van Houten et al. Filamentous phage as an immunogenic carrier to elicit focused antibody responses against a synthetic peptide
EP1135162B1 (fr) Presentation moleculaire ordonnee d'allergenes, procede de preparation et utilisation
van Houten et al. Engineering filamentous phage carriers to improve focusing of antibody responses against peptides
JP3993605B2 (ja) 合成ペプチド免疫原のための免疫刺激因子としての人工的ｔヘルパー細胞エピトープ
US5723129A (en) GnRH-leukotoxin chimeras
US6261569B1 (en) Retro-, inverso- and retro-inverso synthetic peptide analogues
KR100222163B1 (ko) 캡시드를 형성하고 시스테인 변형된 키메라 ms-2 코트 단백질
Minenkova et al. Design of specific immunogens using filamentous phage as the carrier
JP2858848B2 (ja) Ｂ型肝炎ウイルスコア抗原粒子
US6171591B1 (en) Recombinant nodavirus compositions and methods
US7115266B2 (en) Angiotensin peptide-carrier conjugates and uses thereof
JP2015205881A5 (fr)
Perham et al. Engineering a peptide epitope display system on filamentous bacteriophage
JPH0768266B2 (ja) ネコ科白血病ウイルスワクチン
NZ220027A (en) Antigens or haptens coupled to escherichia coli outer membrane proteins for enhancement of immune response
US5763574A (en) HIV-specific synthetic antigens and their use
JP3238396B2 (ja) 担体結合組換えタンパク質、その製造方法並びに免疫原及びワクチンとしての使用
Santoni et al. Plant virus nanoparticles for vaccine applications
CA2286301A1 (fr) Bacteriophage filamenteux utilise comme structure multivalente pour le couplage des peptides synthetiques
AU634837B2 (en) Malaria vaccine

Legal Events

Date Code Title Description
FZDE Dead